top of page
S375_aSMA-PK_2_40XSnapshot1.tif

Press Release

S375_PD1-PDL1-IFNg_3_40XSnapshot1.tif

Our approach aims at reprogramming the solid tumor microenvironment to unlock the full potential of cancer immunotherapy.

Icone collegamenti_Tavola disegno 1 copia 46.png
S379_CD3 CD4 CD8 40x_2Snapshot1 copia.tif
Icone collegamenti.png

Join Lever Bio in advancing promising research and driving innovative drug development in the immuno-oncology field

bottom of page